| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | C A Heyneman | |
| J Erramouspe | |||
| P2860 | cites work | Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies | Q28296998 |
| Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis | Q29011885 | ||
| Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction | Q30472404 | ||
| Sulphamethoxazole prophylaxis in the otitis-prone child | Q30495085 | ||
| A Novel Use of Xylitol Sugar in Preventing Acute Otitis Media | Q57589250 | ||
| Prevention of Recurrent Acute Otitis Media in Otitis-prone Children by Intermittent Prophylaxis with Penicillin | Q58083179 | ||
| Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network. | Q30501910 | ||
| Clinical implications of antibiotic resistance for management of acute otitis media | Q31956655 | ||
| Pneumococcal conjugate vaccines | Q33677419 | ||
| Fundamental basis for rational therapeutics in acute otitis media | Q33802469 | ||
| Antimicrobial therapy of acute otitis media: review of treatment recommendations | Q33845893 | ||
| Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group | Q33896897 | ||
| The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children | Q34467468 | ||
| Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial | Q36601010 | ||
| A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe | Q36942973 | ||
| Strategies to control recurrent acute otitis media in infants and children | Q37536374 | ||
| The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio | Q39231797 | ||
| Prevention of otitis media in children by pneumococcal vaccination | Q39313283 | ||
| Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life | Q39440578 | ||
| Language, speech sound production, and cognition in three-year-old children in relation to otitis media in their first three years of life. | Q39535729 | ||
| In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media | Q39779018 | ||
| Effect of xylitol on growth of nasopharyngeal bacteria in vitro | Q39780241 | ||
| Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials | Q40720912 | ||
| Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia. | Q41091457 | ||
| A meta-analytic review of the risk factors for acute otitis media | Q41092299 | ||
| Acute otitis media in the 1990s: the impact of antibiotic resistance | Q41729998 | ||
| Preventing otitis media: medical approaches | Q41730007 | ||
| Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae | Q42538546 | ||
| Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis | Q42783739 | ||
| Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media | Q43880282 | ||
| Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children | Q44606988 | ||
| Potential cost savings attributable to influenza vaccination of school-aged children | Q44861354 | ||
| Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamethoxazole prophylaxis. | Q45138312 | ||
| Myringotomy in acute otitis media. A controlled study | Q45167524 | ||
| What role for antibiotics in otitis media and sinusitis? | Q46224882 | ||
| Continuous twice daily or once daily amoxicillin prophylaxis compared with placebo for children with recurrent acute otitis media. | Q50621153 | ||
| Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric medicaid population. | Q50625151 | ||
| Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection. | Q52035923 | ||
| Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. | Q52039837 | ||
| Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. | Q52039942 | ||
| Maternal cigarette smoking during pregnancy is an independent predictor for symptoms of middle ear disease at five years' postdelivery. | Q52175448 | ||
| Strategies for dealing with amoxicillin failure in acute otitis media. | Q52225095 | ||
| Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team. | Q53148418 | ||
| One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. | Q53931106 | ||
| Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. | Q54086013 | ||
| Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. | Q54105670 | ||
| Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media. | Q54110000 | ||
| Management of acute otitis media caused by resistant pneumococci in infants. | Q54129835 | ||
| Treatment of acute otitis media in an era of increasing microbial resistance. | Q54132298 | ||
| Protecting the therapeutic advantage of antimicrobial agents used for otitis media. | Q54132361 | ||
| Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. | Q54151658 | ||
| Comparison of Ceftriaxone and Trimethoprim-Sulfamethoxazole for Acute Otitis Media | Q57031320 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1452-1468 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Annals of Pharmacotherapy | Q4767858 |
| P1476 | title | treatment and prevention of otitis media | |
| P478 | volume | 34 |
| Q42056689 | Amoxicillin/clavulanic acid is ineffective at preventing otitis media in children with presumed viral upper respiratory infection: a randomized, double-blind equivalence, placebo-controlled trial. |
| Q35814359 | Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections |
| Q34796973 | Conjugated heptavalent pneumococcal vaccine |
| Q37590854 | Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV). |
| Q35537827 | Short-course antimicrobial therapy of respiratory tract infections |
| Q44741658 | What is optimal for antibiotic studies in acute otitis media? |
Search more.